An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cardiovascular Systems, Inc. (CSII) will announce its fourth-quarter results on August 2. Instead of a traditional earnings call, company management will discuss these results during its capital markets day on August 3. The live webcast is scheduled to begin at 9:00 a.m. CT (10:00 a.m. ET). The company focuses on developing innovative medical devices for vascular and coronary treatments, aiming to improve current treatment methods.
Positive
Management will discuss fourth-quarter results in a dedicated session, providing a focused platform for investors.
CSII specializes in innovative solutions for treating vascular and coronary diseases.
Negative
None.
Webcast of Capital Markets Day on August 3 will include discussion of fiscal fourth-quarter results
ST. PAUL, Minn.--(BUSINESS WIRE)--
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will release fourth-quarter results the evening of August 2. In lieu of hosting a quarterly earnings conference call, CSI management will discuss fourth-quarter results at the beginning of its capital markets day on August 3. The webcast of the capital markets day will begin on Wednesday, August 3, 2022, at 9:00 a.m. CT (10:00 a.m. ET).
To access the live webcast click here. A webcast replay will be available later the same day.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For more information, visit www.csi360.com and follow us on LinkedIn and Twitter.
Cardiovascular Systems, Inc. Jack Nielsen Vice President, Investor Relations & Corporate Communications
(651) 202-4919
j.nielsen@csi360.com
Source: Cardiovascular Systems, Inc.
FAQ
When will Cardiovascular Systems, Inc. release its fourth-quarter earnings?
Cardiovascular Systems, Inc. will release its fourth-quarter earnings on August 2.
What time is the capital markets day for CSII?
The capital markets day for CSII is scheduled for August 3 at 9:00 a.m. CT.
How can I access the webcast for CSII's capital markets day?
You can access the live webcast for CSII's capital markets day through their official website or [here](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fcsi-capital-markets-day-2022.open-exchange.net%2Fregistration&esheet=52777854&newsitemid=20220713005031&lan=en-US&anchor=here&index=1&md5=5962fa3960d0e011db9be1f02d9bef0c).
What is the focus of Cardiovascular Systems, Inc.'s products?
CSII focuses on developing innovative medical devices for treating vascular and coronary diseases.
